HuGE Literature Finder
Records 1-9
Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design.
Clinical lung cancer 2020 Oct . Riess Jonathan W, Frankel Paul, Shackelford David, Dunphy Mark, Badawi Ramsey D, Nardo Lorenzo, Cherry Simon R, Lanza Ian, Reid Joel, Gonsalves Wilson I, Kunos Charles, Gandara David R, Lara Primo N, Newman Edward, Paik Paul |
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden.
Annals of oncology : official journal of the European Society for Medical Oncology 2020 Aug . Marinelli D, Mazzotta M, Scalera S, Terrenato I, Sperati F, D'Ambrosio L, Pallocca M, Corleone G, Krasniqi E, Pizzuti L, Barba M, Carpano S, Vici P, Filetti M, Giusti R, Vecchione A, Occhipinti M, Gelibter A, Botticelli A, De Nicola F, Ciuffreda L, Goeman F, Gallo E, Visca P, Pescarmona E, Fanciulli M, De Maria R, Marchetti P, Ciliberto G, Maugeri-Saccà |
EGFR-mutant lung adenocarcinoma harboring co-mutational tumor suppressor genes predicts poor prognosis.
Journal of cancer research and clinical oncology 2020 May . Zhao Yue, Pan Yunjian, Cheng Chao, Zheng Difan, Zhang Yang, Gao Zhendong, Fu Fangqiu, Li Hang, Zheng Shanbo, Zhuge Lingdun, Mao Hengyu, Kuang Muyu, Tao Xiaoting, Peng Yizhou, Hu Hong, Xiang Jiaqing, Li Yuan, Sun Yihua, Chen Haiqu |
Less immune cell infiltration and worse prognosis after immunotherapy for patients with lung adenocarcinoma who harbored STK11 mutation.
International immunopharmacology 2020 May 84 106574. Wang Haiyong, Guo Jun, Shang Xiaoling, Wang Zheh |
[Nrf2 and Keap1 Abnormalities in 104 Lung Adenocarcinoma Cases and Association with Clinicopathologic Features].
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2018 Mar 21 (3): 241-250. Xiao Yu, Zhu Xiang, Gu Yangchun, Chen Sen, Liang Li, Cao Baosh |
Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Oct . Arbour Kathryn C, Jordan Emmet J, Kim Hyunjae Ryan, Dienstag Jordan, Yu Helena, Sanchez-Vega Francisco, Lito Piro, Berger Michael F, Solit David B, Hellmann Matthew D, Kris Mark G, Rudin Charles M, Ni Andy, Arcila Maria E, Ladanyi Marc, Riely Gregory |
Keap1 mutations in lung cancer patients.
Oncology letters 2013 Sep 6 (3): 719-721. Sasaki Hidefumi, Suzuki Ayumi, Shitara Masayuki, Okuda Katsuhiro, Hikosaka Yu, Moriyama Satoru, Yano Motoki, Fujii Yoshita |
Association of keap1 and nrf2 genetic mutations and polymorphisms with endometrioid endometrial adenocarcinoma survival.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011 Nov 21 (8): 1428-35. Wong Tze Fang, Yoshinaga Kousuke, Monma Yasutake, Ito Kiyoshi, Niikura Hitoshi, Nagase Satoru, Yamamoto Masayuki, Yaegashi Nob |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: